IS5572A - Energy-rich cyclodextrin complexes - Google Patents
Energy-rich cyclodextrin complexesInfo
- Publication number
- IS5572A IS5572A IS5572A IS5572A IS5572A IS 5572 A IS5572 A IS 5572A IS 5572 A IS5572 A IS 5572A IS 5572 A IS5572 A IS 5572A IS 5572 A IS5572 A IS 5572A
- Authority
- IS
- Iceland
- Prior art keywords
- rich
- energy
- cyclodextrin complexes
- cyclodextrin
- complexes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7554498P | 1998-02-23 | 1998-02-23 | |
PCT/IS1999/000003 WO1999042111A1 (en) | 1998-02-23 | 1999-02-16 | High-energy cyclodextrin complexes |
Publications (1)
Publication Number | Publication Date |
---|---|
IS5572A true IS5572A (en) | 2000-08-16 |
Family
ID=22126450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5572A IS5572A (en) | 1998-02-23 | 2000-07-25 | Energy-rich cyclodextrin complexes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1067942A1 (en) |
JP (1) | JP2003522207A (en) |
AU (1) | AU759280C (en) |
CA (1) | CA2320772A1 (en) |
IS (1) | IS5572A (en) |
NZ (1) | NZ505951A (en) |
WO (1) | WO1999042111A1 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030391A2 (en) * | 1999-10-27 | 2001-05-03 | Farmarc Nederland Bv | Pharmaceutical composition containing midazolam |
CA2401424C (en) * | 2000-03-28 | 2011-02-08 | Farmarc Nederland Bv | Alprazolam inclusion complexes and pharmaceutical compositions thereof |
DK1406633T3 (en) | 2001-06-18 | 2011-10-31 | Noven Pharma | Improved drug delivery in transdermal systems |
WO2003022270A1 (en) * | 2001-09-13 | 2003-03-20 | Noven Pharmaceuticals, Inc. | Transdermal administration of an enalapril ester |
US6805878B2 (en) | 2001-09-13 | 2004-10-19 | Noven Pharmaceuticals, Inc. | Transdermal administration of ACE inhibitors |
SI1515729T1 (en) * | 2002-06-13 | 2008-08-31 | Novartis Ag | Quaternised ammonium cyclodextrin compounds |
PL1608344T3 (en) | 2003-03-28 | 2011-01-31 | Ares Trading Sa | Oral formulations of cladribine |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
EP1729724A4 (en) | 2003-12-31 | 2008-07-23 | Cydex Inc | Inhalent formulation containing sulfoalkyl ether gamma-cyclodextryn and corticosteroid |
GB0400804D0 (en) | 2004-01-14 | 2004-02-18 | Innoscience Technology Bv | Pharmaceutical compositions |
JP2007534693A (en) | 2004-04-23 | 2007-11-29 | サイデックス・インコーポレイテッド | DPI formulation containing sulfoalkyl ether cyclodextrin |
US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
PT2335707E (en) | 2005-10-26 | 2015-09-10 | Cydex Pharmaceuticals Inc | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
WO2008067027A2 (en) * | 2006-10-20 | 2008-06-05 | Icos Corporation | Compositions of chkl inhibitors and cyclodextrin |
MX2009005368A (en) * | 2006-11-21 | 2009-06-05 | Novartis Ag | Stable parenteral formulation containing a rsv inhibitor of a benzodiazepine structure. |
KR20160033792A (en) | 2007-04-27 | 2016-03-28 | 사이덱스 파마슈티칼스, 인크. | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use |
EP2106786A1 (en) * | 2008-04-04 | 2009-10-07 | Roewer, Norbert, Univ.-Prof. Dr. med. | Pharmaceutical preparation comprising permethylated cyclodextrin |
US7635773B2 (en) | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
WO2010053487A1 (en) | 2008-11-07 | 2010-05-14 | Cydex Pharmaceuticals, Inc. | Composition containing sulfoalkyl ether cyclodextrin and latanoprost |
EA201170897A1 (en) | 2008-12-29 | 2011-12-30 | Унилевер Н.В. | FOOD PRODUCTS ENRICHED WITH METHYLXANTHINES |
US8236782B2 (en) | 2009-05-13 | 2012-08-07 | Cydex Pharmaceuticals, Inc. | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
EP2571502B1 (en) | 2010-05-19 | 2016-04-27 | Unilever N.V. | Theobromine for increasing hdl-cholesterol |
CN103502224A (en) | 2011-02-23 | 2014-01-08 | 克鲁莱斯有限公司 | Flumazenil complexes, compositions comprising same and uses thereof |
JP6508944B2 (en) | 2012-02-15 | 2019-05-08 | サイデックス・ファーマシューティカルズ・インコーポレイテッド | Method of preparation for cyclodextrin derivatives |
CA2865950C (en) | 2012-02-28 | 2016-12-20 | Cydex Pharmaceuticals, Inc. | Alkylated cyclodextrin compositions and processes for preparing and using the same |
MX360192B (en) | 2012-10-22 | 2018-10-24 | Cydex Pharmaceuticals Inc | Alkylated cyclodextrin compositions and processes for preparing and using the same. |
US9925274B2 (en) | 2012-11-15 | 2018-03-27 | Sapiotec Gmbh | Delphinidin complex as an antiphlogistic or immunosuppressive active ingredient |
EP2931287B1 (en) | 2012-12-11 | 2017-10-04 | Sapiotec GmbH | Delphinidin for combating melanoma cells |
US10851184B2 (en) | 2014-08-22 | 2020-12-01 | Cydex Pharmaceuticals, Inc. | Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
KR0166088B1 (en) * | 1990-01-23 | 1999-01-15 | . | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
US5324718A (en) * | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
-
1999
- 1999-02-16 EP EP99906440A patent/EP1067942A1/en not_active Withdrawn
- 1999-02-16 NZ NZ505951A patent/NZ505951A/en unknown
- 1999-02-16 CA CA002320772A patent/CA2320772A1/en not_active Abandoned
- 1999-02-16 JP JP2000532126A patent/JP2003522207A/en not_active Withdrawn
- 1999-02-16 AU AU26385/99A patent/AU759280C/en not_active Ceased
- 1999-02-16 WO PCT/IS1999/000003 patent/WO1999042111A1/en not_active Application Discontinuation
-
2000
- 2000-07-25 IS IS5572A patent/IS5572A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ505951A (en) | 2003-02-28 |
WO1999042111A1 (en) | 1999-08-26 |
JP2003522207A (en) | 2003-07-22 |
AU2638599A (en) | 1999-09-06 |
AU759280B2 (en) | 2003-04-10 |
CA2320772A1 (en) | 1999-08-26 |
EP1067942A1 (en) | 2001-01-17 |
AU759280C (en) | 2004-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS5572A (en) | Energy-rich cyclodextrin complexes | |
DK1075281T3 (en) | Polyol-IFN- beta conjugates | |
ATE236136T1 (en) | BENZOSULFONE DERIVATIVES | |
NO994875L (en) | Connected metal complexes | |
ATE259810T1 (en) | PHENYL-XANTHINE DERIVATIVES | |
DE59907315D1 (en) | VEHICLE CALCULATOR ARRANGEMENT | |
ATE234316T1 (en) | METALLOCENE COMPLEXES | |
DE69902762D1 (en) | RISER-SPAN ARRANGEMENT | |
DE69925655D1 (en) | Taillight | |
DK1115716T3 (en) | 2-phenylpyran-4-one derivatives | |
ATE233253T1 (en) | CHROMEDER DERIVATIVES | |
DK1134219T3 (en) | Cucloalkyl-substituted aminomethylpyrrolidine derivatives | |
DK1060183T3 (en) | 5-deoxycytidine derivatives | |
FI980759A0 (en) | Taetningskonstruktion Foer suglaodan i en sugvals | |
DE29804387U1 (en) | sunroof | |
DE29805839U1 (en) | Box furniture | |
DE29813464U1 (en) | Carrying arrangement | |
DE59907635D1 (en) | PYRAZOLYLDIOXOTHIOCHROMANOYL DERIVATIVES | |
DE29800263U1 (en) | Worktable | |
DE29808121U1 (en) | flap | |
SE9901098L (en) | benefits Box | |
DE29815391U1 (en) | HF-tight bushing | |
DE29807387U1 (en) | Close | |
FI980743A0 (en) | Gap-valsformare i en pappersmaskin | |
DE29817982U1 (en) | box |